Science Explorer Back to mapMap
Discussion
Research works
30
▲ 8% vs 2018-21
Citations
630
21.2 per fractional work
Top-10% rate
4.0%
all institutions 10.0%
Open access
71%
world 40%
International
19%
world 18%

Not ranked overall: Debiotech (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Debiotech (Switzerland) work in?

In all years, 69% of research at Debiotech (Switzerland) is in Physical Sciences, 20% in Health Sciences. Its largest fields are Engineering (59%), Medicine (20%), Neuroscience (5%). It does 1.6× the world's share of Physical Sciences.

Physical Sciences: 20 fractional works · 68.9% of its workEngineering: 18 fractional works · 59.2% of its workBiomedical Engineering: 13 fractional works · 43.7% of its workElectrical and Electronic Engineering: 2 fractional works · 8.0% of its workComputational Mechanics: 1 fractional works · 3.2% of its workControl and Systems Engineering: 0 fractional works · 1.1% of its workOcean Engineering: 0 fractional works · 1.1% of its workAerospace Engineering: 0 fractional works · 0.6% of its workAutomotive Engineering: 0 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.6% of its workMedia Technology: 0 fractional works · 0.4% of its workPhysics and Astronomy: 1 fractional works · 3.0% of its workCondensed Matter Physics: 0 fractional works · 1.7% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.9% of its workNuclear and High Energy Physics: 0 fractional works · 0.4% of its workComputer Science: 1 fractional works · 2.8% of its workHuman-Computer Interaction: 0 fractional works · 0.7% of its workArtificial Intelligence: 0 fractional works · 0.6% of its workComputer Graphics and Computer-Aided Design: 0 fractional works · 0.6% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.6% of its workInformation Systems: 0 fractional works · 0.4% of its workChemical Engineering: 1 fractional works · 2.3% of its workBioengineering: 1 fractional works · 2.3% of its workMaterials Science: 0 fractional works · 1.0% of its workBiomaterials: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.4% of its workGeophysics: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.2% of its workHealth Sciences: 6 fractional works · 19.8% of its workMedicine: 6 fractional works · 19.7% of its workSurgery: 2 fractional works · 5.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 4.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.4% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.2% of its workNeurology: 1 fractional works · 1.8% of its workPhysiology: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workEmergency Medicine: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 3 fractional works · 9.6% of its workNeuroscience: 2 fractional works · 5.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 4.1% of its workCognitive Neuroscience: 0 fractional works · 0.9% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 2.0% of its workMolecular Biology: 0 fractional works · 1.4% of its workBiophysics: 0 fractional works · 0.6% of its workImmunology and Microbiology: 1 fractional works · 1.9% of its workVirology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.6% of its workMicrobiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 1.7% of its workSocial Sciences: 0 fractional works · 1.4% of its workSociology and Political Science: 0 fractional works · 0.7% of its workSafety Research: 0 fractional works · 0.4% of its workUrban Studies: 0 fractional works · 0.4% of its workArts and Humanities: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKDebiotech(Switzerland)30fractional works, all years
Life Sciences10%Physical Sciences69%Health Sciences20%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Engineering1859.2%
    2. Physics and Astronomy13.0%
    3. Computer Science12.8%
    4. Chemical Engineering12.3%
    5. Materials Science01.0%
    6. Earth and Planetary Sciences00.4%
    7. Chemistry00.2%
    1. Medicine619.7%
    2. Health Professions00.1%
    1. Neuroscience25.1%
    2. Biochemistry, Genetics and Molecular Biology12.0%
    3. Immunology and Microbiology11.9%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Social Sciences01.4%
    2. Arts and Humanities00.1%
    3. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Neuroscience: 4.38× its world share, 0 worksNeuroscienceComputer Science: 0.23× its world share, 0 worksComputer ScienceEngineering: 3.91× its world share, 4 worksEngineeringPhysics and Astronomy: 1.20× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.18× its world share, 0 worksHealth ProfessionsMedicine: 1.33× its world share, 2 worksMedicineArts and Humanities: 0.23× its world share, 0 worksArts and HumanitiesPsychology: 0.22× its world share, 0 worksPsychologySocial Sciences: 0.19× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.4×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Neuroscience4.38×0 works
  2. Engineering3.91×4 works
  3. Medicine1.33×2 works
  4. Physics and Astronomy1.20×0 works
  5. Computer Science0.23×0 works
  6. Arts and Humanities0.23×0 works
  7. Psychology0.22×0 works
  8. Social Sciences0.19×0 works
  9. Health Professions0.18×0 works

Who are the top researchers at Debiotech (Switzerland)?

Ranked on the quality score, E. Chappel lead among researchers whose main affiliation is Debiotech (Switzerland).

  1. 1 E. Chappel Switzerland · #4,100,234 worldwide 728 citations · 51 works
All ranked researchers at Debiotech (Switzerland)

What are the most cited papers from Debiotech (Switzerland)?

The most cited paper from Debiotech (Switzerland) is "Static micromixers based on large-scale industrial mixer geometry" (Arnaud Bertsch, Stephan Heimgartner, Peter Cousseau et al., 2001), with 200 citations. Next come "Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis" (164) and "Inhalation of vasoactive intestinal peptide in pulmonary hypertension" (131).

Most cited papers
#PaperReleasedCitations
1 Static micromixers based on large-scale industrial mixer geometry Arnaud Bertsch, Stephan Heimgartner, Peter Cousseau et al. · Lab on a Chip Open access 2001 200
2 Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis Antje Prasse, Gernot Zissel, Niklas Lützen et al. · American Journal of Respiratory and Critical Care Medicine 4 May 2010 164
3 Inhalation of vasoactive intestinal peptide in pulmonary hypertension Hanno H. Leuchte, Carlos J. Baezner, R. A. Baumgartner et al. · European Respiratory Journal Open access 31 Oct 2008 131
4 A high-performance silicon micropump for disposable drug delivery systems D. Maillefer, Siegfried F. Gamper, B. Frehner et al. Conference paperOpen access 13 Nov 2002 104
5 A high-performance silicon micropump for an implantable drug delivery system D. Maillefer, Harald van Lintel, Gilles Rey-Mermet et al. Conference paper 1999 98
All 48 most cited papers, with filters and sorting

Which keywords describe research at Debiotech (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Lab-on-a-Chip, 3D Printing, Biomedical Research, Poly(dimethylsiloxane), Microfluidics, Biomedical Applications, Dielectrophoresis and Acoustic Manipulation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Lab-on-a-Chip8▲ 206×3 topics
  2. 3D Printing5▲ 97×2 topics
  3. Biomedical Research5▲ 234×1 topic
  4. Poly(dimethylsiloxane)5▲ 366×1 topic
  5. Microfluidics5▲ 195×3 topics
  6. Biomedical Applications4▲ 13×7 topics
  7. Dielectrophoresis3▲ 206×2 topics
  8. Acoustic Manipulation3▲ 243×1 topic
  9. Particle Separation3▲ 243×1 topic
  10. Continuous Flow Chemistry2▲ 179×1 topic
  11. Droplet Formation2▲ 179×1 topic
  12. Drug Delivery2▲ 11×3 topics
  13. Cardiovascular Disease2▲ 4.5×3 topics
  14. Neurological Disorders2▲ 7.5×5 topics
  15. Diabetes1▲ 8.4×3 topics
  16. Glycemic Control1▲ 32×3 topics
  17. Insulin Therapy1▲ 39×2 topics
  18. Machine Learning1▲ 2.1×5 topics
  19. Continuous Glucose Monitoring1▲ 90×1 topic
  20. Hypoglycemia1▲ 90×1 topic

Which research topics does Debiotech (Switzerland) publish most on?

By volume in 2022-now: Microfluidic and Capillary Electrophoresis Applications, Microfluidic and Bio-sensing Technologies, Diabetes Management and Research and Soft Robotics and Applications.

  1. 1 Microfluidic and Capillary Electrophoresis Applications Biomedical Engineering 1 works
  2. 2 Microfluidic and Bio-sensing Technologies Biomedical Engineering 1 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  4. 4 Soft Robotics and Applications Biomedical Engineering 0 works
  5. 5 3D Printing in Biomedical Research Biomedical Engineering 0 works
  6. 6 Cerebrospinal fluid and hydrocephalus Cellular and Molecular Neuroscience 0 works
  7. 7 Healthcare Technology and Patient Monitoring Surgery 0 works
  8. 8 ECG Monitoring and Analysis Cardiology and Cardiovascular Medicine 0 works
  9. 9 Lattice Boltzmann Simulation Studies Computational Mechanics 0 works
  10. 10 Intravenous Infusion Technology and Safety Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.4%not open28.6%

World: 40% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 18% is written across borders.

How has Debiotech (Switzerland)'s research output changed?

Output in 2022-2025 was 8% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Debiotech (Switzerland) as a percentage of every work published that year, 0.000011% in 2024.

still counting0.000050%0.00010%0.00015%Debiotech (Switzerland)0.0000082% in 2025200020102020

Fractional works of Debiotech (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lausanne

All research institutions in Lausanne

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Debiotech (Switzerland). Posts are plain text and can be reported.